On the day, 728560 shares were traded.
Ratios:
Our goal is to gain a better understanding of ZNTL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.16 and its Current Ratio is at 7.16. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wedbush on November 08, 2023, Downgraded its rating to Neutral and sets its target price to $12 from $38 previously.
On November 07, 2023, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $15.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 12 ’24 when Epperly Melissa B, sold 2,573 shares for $11.44 per share. The transaction valued at 29,435 led to the insider holds 451,449 shares of the business.
Gallagher Cam sold 1,173 shares of ZNTL for $13,419 on Feb 12 ’24. The President now owns 643,277 shares after completing the transaction at $11.44 per share. On Feb 02 ’24, another insider, Gallagher Cam, who serves as the President of the company, sold 11,552 shares for $11.54 each. As a result, the insider received 133,310 and left with 644,450 shares of the company.
Stock Price History:
Over the past 52 weeks, ZNTL has reached a high of $31.46, while it has fallen to a 52-week low of $9.56.
Shares Statistics:
A total of 70.77M shares are outstanding, with a floating share count of 63.80M. Insiders hold about 10.05% of the company’s shares, while institutions hold 109.92% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Tema Neuroscience and Mental He different market analysts. The consensus estimate for the next quarter is $20.20, with high estimates of $22.40 and low estimates of $13.41.
EPS for the following year is $Stocks, with Stocks analysts recommending between $ETF and $Stocks.
